CRS: BJMC
Position: Pharmacist of Record
CRS: Whitman-Walker
CRS: JHU
Position: Pharmacist, PharmD, Investigational Drug Pharmacy
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
